Restore Health today announced it has entered into an agreement to acquire the compounding pharmacy assets of Diplomat Pharmacy, Inc. DPLO, +0.28% the nation's largest independent specialty pharmacy. The agreement further establishes Restore Health's commitment to the compounding pharmacy and personalized medicine space while allowing Diplomat to focus resources on its core specialty pharmacy operations.
Continue reading

Restore Secures Another Clinical Trial with Ironshore

Tuesday, August 4, 2015 | 09:57 AM
Ironshore Pharmaceuticals & Development, Inc. ("Ironshore") has signed an agreement with Restore Health, a company specializing in personalized medicine, to participate in the fulfillment of a double-blind clinical trial, designed to evaluate the safety and efficacy of HLD-200, a new drug in development to treat Attention-deficit/hyperactivity disorder (ADHD). This is Restore's second clinical trial program with Ironshore.
Continue reading

Restore Health's Metabolic Supplement

Monday, August 3, 2015 | 01:42 PM
90% of the American population is vitamin deficient because of poor food quality; lack of access to readily available antioxidant-dense, clean organic fruits and vegetables; and vitamin depletion from medications, alcohol, and environmental toxins.
Continue reading
Search Blog